MedTrace Logo

Adding VR-Based Episodic Future Thinking Training to Executive- Function Training for Children With ADHD: A Randomized Controlled Trial

NCT07591896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-05-18

No results posted yet for this study

Summary

This study recruited 80 children aged 5-12 with clinically diagnosed ADHD from Qilu Hospital, Shandong University, and randomly divided them into two groups with 40 children in each group: the EF-only group and the EF+VR-EFT group. Both groups received a 2-week intervention with 5 sessions per week

Conditions

  • ADHD

Interventions

BEHAVIORAL

executive function

Control Group (EF-only group): Participants received a 2-week standardized, non-immersive conventional executive function (EF) training, with 6 sessions per week (45 minutes per session) under researcher supervision, targeting core executive processes such as inhibitory control and working memory. Experimental Group (EF+VR-EFT group): On the basis of the same conventional EF training as the control group, participants additionally completed a 20-minute VR-based episodic future thinking (VR-EFT) module per session, delivered via PICO headsets through immersive gameplay in a controlled clinical setting.

BEHAVIORAL

a VR-based episodic future thinking

Experimental Group (EF+VR-EFT group): On the basis of the same 2-week conventional EF training, participants additionally completed a VR-based episodic future thinking (VR-EFT) module in each session. Their executive function achieved more significant and stable improvements, particularly in higher-order domains.

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-12-01
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07591896 on ClinicalTrials.gov